AGREEMENT AND PLAN OF MERGER by and among JOHNSON & JOHNSON, CHARM MERGER SUB, INC. and AMBRX BIOPHARMA, INC. Dated as of January 5, 2024Agreement and Plan of Merger • January 8th, 2024 • Ambrx Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of January 5, 2024 by and among Johnson & Johnson, a New Jersey corporation (“Parent”), Charm Merger Sub, Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent (“Merger Sub”), and Ambrx Biopharma, Inc., a Delaware corporation (the “Company”).
